Correlation Between GlaxoSmithKline PLC and Calvert Moderate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Calvert Moderate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Calvert Moderate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Calvert Moderate Allocation, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Calvert Moderate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Calvert Moderate. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Calvert Moderate.

Diversification Opportunities for GlaxoSmithKline PLC and Calvert Moderate

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between GlaxoSmithKline and Calvert is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Calvert Moderate Allocation in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calvert Moderate All and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Calvert Moderate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calvert Moderate All has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Calvert Moderate go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Calvert Moderate

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 2.45 times less return on investment than Calvert Moderate. In addition to that, GlaxoSmithKline PLC is 2.23 times more volatile than Calvert Moderate Allocation. It trades about 0.01 of its total potential returns per unit of risk. Calvert Moderate Allocation is currently generating about 0.06 per unit of volatility. If you would invest  1,798  in Calvert Moderate Allocation on August 30, 2024 and sell it today you would earn a total of  324.00  from holding Calvert Moderate Allocation or generate 18.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Calvert Moderate Allocation

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Calvert Moderate All 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Calvert Moderate Allocation are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Calvert Moderate is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Calvert Moderate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Calvert Moderate

The main advantage of trading using opposite GlaxoSmithKline PLC and Calvert Moderate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Calvert Moderate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calvert Moderate will offset losses from the drop in Calvert Moderate's long position.
The idea behind GlaxoSmithKline PLC ADR and Calvert Moderate Allocation pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency